Structured Summary
Introduction Musculoskeletal injuries (MSKI) are the most common clinical condition in the military that affect medical readiness. Evaluation of MSKI burden and the effects of these injuries on readiness in large deck Navy ships is warranted.
Materials and Methods A retrospective cohort study assessing population-level MSKI rates, limited duty (LIMDU), and long-term disability episode counts of all Sailors assigned to US Navy Aircraft Carriers (CVNs) and Amphibious Assault Ships (LHA/LHD) from November 2016 to February 2023 were extracted from the Musculoskeletal Naval Epidemiological Surveillance Tool. A negative binomial regression and general additive (gaussian) models evaluated the association of ship platform, deployment status, days underway, and sex on MSKI rates and the proportion of cases that resulted in LIMDU, returned-to-duty following LIMDU, or progressed to long-term disability.
Results Sailors attached to CVNs contributed a mean 17893.8±23280.6 person-months, with those attached to LHA/LHDs contributing an average 5981.8±8432.7 person-months. Aboard CVNs, MSKI occurred at a rate of 0.30±0.16/1000 person-months while deployed and 0.64±0.31/1000 person-months in homeport. Aboard LHA/LHDs, Sailors incurred MSKI at a rate of 0.59±0.58/1000 person-months while on deployment and 1.24±0.68/1000 person-months in homeport. Among Sailors aboard CVNs, LIMDU occurred in 7.95±7.75% of MSKI cases while deployed and 5.13±5.26% while in homeport. Aboard LHA/LHDs, 8.57±13.42% of MSKI cases were placed on LIMDU while deployed and 4.95±5.27% while in homeport. In the multivariable assessment of LIMDU, being deployed underway was a significant factor (B=3.62 p=.03, variance explained=3.86%). Sailors that were female and served aboard LHA/LHDs returned to full duty at a significantly greater frequency compared to their male counterparts and Sailors serving aboard CVNs. None of the independent variables evaluated were associated with long-term disability.
Conclusion The findings in the current study demonstrate the substantial burden of MSKI aboard large deck ships, both in homeport and while deployed. Inclusion of a PT aboard LHA/LHDs, like the CVN, may help to prevent and mitigate the effects of MSKI through early access to specialized care and integral injury prevention and performance optimization methods.
Competing Interest Statement
Dr Fraser reports grants from Congressionally Directed Medical Research Programs and the Office of Naval Research, outside of the submitted work. In addition, Dr Fraser has a patent pending for an Adaptive and Variable Stiffness Ankle Brace, U.S. Provisional Patent Application No. 63254,474.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center Institutional Review Board protocol, number NHRC.2022.0201-NHSR.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* email: john.j.fraser{at}uky.edu. phone: (757) 438-0390; Twitter: @NavyPT
Email: joshph{at}bgsu.edu.
Email: mrosenthal{at}unmc.edu
Declarations: Dr Fraser reports grants from Congressionally Directed Medical Research Programs and the Office of Naval Research, outside of the submitted work. In addition, Dr Fraser has a patent pending for an Adaptive and Variable Stiffness Ankle Brace, U.S. Provisional Patent Application No. 63254,474.
Prior Presentation. None
Clinical Trial Registration: Not applicable
Sources of Support / Funding Sources: None
Competing Interests: None
Institutional Review Board (Human Subjects): The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center Institutional Review Board protocol, number NHRC.2022.0201-NHSR.
Institutional Animal Care and Use Committee (IACUC): Not applicable
Data Availability: All data relevant to the study are included in the article or are available as supplementary files.
Disclaimer: The opinions and assertions expressed herein are those of the author(s) and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences or the Department of Defense.
Institutional Clearance: Institutional clearance approved.
Data Availability
All data relevant to the study are included in the article or are available as supplementary files.
